Clinical trial
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00090857 |
|---|---|
| Title | Letrozole in Preventing Breast Cancer in Postmenopausal Women |
| Official title | A Pilot Study of Aromatase Inhibitors for Women at Increased Risk of Breast Cancer Based on Estradiol Levels |
| Acronym | WISE |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH Jonsson Comprehensive Cancer Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | Letrozole, Placebo |
| Enrollment | 49 |
| Start date | Feb 1, 2002 |
| Primary completion | Aug 1, 2008 |
| Completion | Mar 1, 2013 |
| First posted | Sep 8, 2004 |
| Last update posted | Mar 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: